Literature DB >> 6323022

Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver.

G Norstedt, R Palmiter.   

Abstract

The secretory pattern of growth hormone (GH) differs between the sexes; in males it is more pulsatile than in females. Experiments were performed to test the hypothesis that differences in the secretory rhythm of GH are responsible for sex-dependent liver functions of mice. Continuous delivery of GH was achieved either by introducing metallothionein-GH fusion genes into the germ line or by implanting minipumps. Pulsatile delivery of GH was mimicked by injection. The effects of these treatments on production of hepatic prolactin/GH receptors, albumin, and major urinary protein (MUP) were monitored. The results suggest that induction of MUP mRNA requires pulsatile occupancy of GH receptors, which is achieved naturally in males or by injection of GH, whereas chronic occupancy of GH receptors is inhibitory. In contrast, induction of prolactin/GH receptors requires chronic stimulation of GH receptors, which is approximated in normal female mice or results from increased GH levels in mice with foreign genes or undergoing infusions from minipumps.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323022     DOI: 10.1016/0092-8674(84)90030-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  51 in total

1.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.

Authors:  G B Udy; R P Towers; R G Snell; R J Wilkins; S H Park; P A Ram; D J Waxman; H W Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.

Authors:  Sumiko Kurachi; Jeffrey S Huo; Afshin Ameri; Kezhong Zhang; Akiyasu C Yoshizawa; Kotoku Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

3.  Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns.

Authors:  Joshua H Wong; Jonathan Dukes; Robert E Levy; Brandon Sos; Sara E Mason; Tina S Fong; Ethan J Weiss
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 4.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

5.  Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.

Authors:  A Matsumoto; Y Seki; M Kubo; S Ohtsuka; A Suzuki; I Hayashi; K Tsuji; T Nakahata; M Okabe; S Yamada; A Yoshimura
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.

Authors:  S J MacKenzie; S J Yarwood; A H Peden; G B Bolger; R G Vernon; M D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Promoter efficiency depends upon intragenic sequences.

Authors:  A M Koltunow; K Gregg; G E Rogers
Journal:  Nucleic Acids Res       Date:  1987-10-12       Impact factor: 16.971

8.  Metal-inducible pathology in the liver, pancreas, and kidney of transgenic mice expressing SV40 early region genes.

Authors:  K R Dyer; A Messing
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

9.  Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice.

Authors:  J O Jansson; S Ekberg; S B Hoath; W G Beamer; L A Frohman
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

10.  Hormonal modulation of sex differences in resistance to Leishmania major systemic infections.

Authors:  B A Mock; C A Nacy
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.